Ω-3 fatty acid supplements for cancer-associated weight loss

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Ω-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease: This review focuses on both the preclinical and clinical data of ω-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.

Original languageEnglish (US)
Pages (from-to)394-399
Number of pages6
JournalNutrition in Clinical Practice
Volume20
Issue number4
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Ω-3 fatty acid supplements for cancer-associated weight loss'. Together they form a unique fingerprint.

  • Cite this